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A 71-year-old woman was referred to our tertiary care
center for evaluation of asymptomatic recurrence of pri-
mary hyperparathyroidism. As per our protocol, the pa-
tient underwent neck/mediastinum 18F-fluorocholine
(FCH) positron emission tomography-computed tomog-
raphy (PET-CT) for localization. In our institution, FCH
PET-CT is performed in patients with hyperparathyroid-
ism and negative conventional imaging [1]. FCH PET-
CT is a promising new imaging modality for detection
of hyperfunctioning parathyroid glands [2, 3]. Thirty
minutes after injection of 139MBq (3.8mCi), the PET-
CT images showed a focal uptake (SUVmax=1.8) at the
lower anterior neck, level VI, anterior to the right com-
mon carotid artery (Fig. 1a-f), suspicious for parathyroid
adenoma. Additionally, it showed a second focal uptake
(SUVmax=2.5) in a nodal structure measuring 1.2cm,
within the outer lower quadrant of the right breast
(Fig. 2a-f). No other pathological uptake was seen. On
the subsequent ultrasound (US) of the breast, there was
an area of microcalcifications seen with no definite ab-
normal lesion. US of the axilla was negative for any
suspicious lesions. Mammography showed a blurry
1 . 3 - c m m a s s w i t h o u t c l e a r b o a r d e r s a n d
microcalcifications within relatively dense fibro-
glandular tissue (BI-RADS IV). US-guided core biopsy
showed papillary carcinoma. Pathological examination
after breast-conserving surgery revealed papillary breast
cancer of 1.0cm, staged pT1N0. The location of the
cancer corresponded with that indicated by FCH PET-
CT. Due to the finding of breast cancer, surgery for
primary hyperparathyroidism was postponed.
Currently, mammography and US are considered the
standard of care in the preoperative workup of breast
cancer [4]. Multiple other imaging modalities, including
positron emission mammography (PEM) with a variety
of radionuclide tracers as well as magnetic resonance
imaging (MRI), are currently under investigation [5–7].
Breast cancer has previously been found to have in-
creased uptake of choline [8]. Therefore, the use of
11C-choline PET/CT has been used to accurately local-
ize these malignant tumors [9]. One major drawback is
that the half-life of 11C-methionine is only 20 min. This
requires on-site production of the tracer to be used in
the study, thereby strongly limiting its clinical applica-
bility. The half-life of FCH is 110 min, enabling off-site
production and distribution, making it much more prac-
tical to use as an imaging modality in this context [10].
Furthermore, FCH is already being used in the evalua-
tion of prostate cancer and is therefore more widely
available than other radiotracers [11, 12].
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As can be seen in the case presented, high FCH uptake was
seen in a small breast cancer. Due to its favorable half-life and
wide availability by its use as a localization technique for
patients with prostate cancer and complicated hyperparathy-
roidism, FCH PET-CT may be a new promising modality in
the imaging of breast cancer.
Fig. 2 18F-Fluorocholine PET-
CT of the neck/mediastinum: axi-
al (a-c) and coronal (d-f) PET, CT
and fused PET-CT images show-
ing an additional focal uptake
(SUVmax=2.5) in a nodal struc-
ture of 1.2cm located in the lateral
lower quadrant of the right breast
Fig. 1 18F-Fluorocholine PET-
CT of the neck/mediastinum: axi-
al (a-c) and coronal (d-f) PET, CT
and fused PET-CT images show-
ing a focal uptake (SUVmax=
1.8) at the lower anterior neck,
level VI, anterior to the right
common carotid artery, suggest-
ing parathyroid adenoma
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